Vertex Pharmaceuticals Inc. Company Profile

03:52 EDT 25th September 2017 | BioPortfolio

Vertex is a global biotechnology company that aims to discover, develop and commercialize innovative new medicines so people with serious diseases can lead better lives. Founded in 1989, Vertex today employs more than 2,000 people at sites around the world.  In addition to our headquarters in Massachusetts, Vertex has research and development sites and other offices in San Diego, CA; Abingdon, Oxfordshire, UK; Laval, Quebec; Coralville, IA; and Geneva, Switzerland.

In May 2011, the U.S. Food and Drug Administration (FDA) approved Vertex’s first medicine, a treatment for hepatitis C.  In January 2012, Vertex received FDA approval for our medicine for cystic fibrosis. Vertex received European approval of our medicine for cystic fibrosis in July 2012.

In addition to our approved medicines, we are developing new combinations of medicines that could further advance treatment of hepatitis C and cystic fibrosis.  We also have a broad pipeline of other potential new medicines currently in early and mid-stage development for diseases such as rheumatoid arthritis, influenza and other diseases.

We collaborate with some of the world’s largest pharmaceutical companies, leading nonprofit disease foundations and many of the world’s best-known academic institutions.


130 Waverly Street
United States of America


Phone: 617-341-6100
Fax: 617-444-6680

News Articles [1432 Associated News Articles listed on BioPortfolio]

For Vertex Pharmaceuticals, Can One Billion-Dollar Breakthrough Beget Another?

Vertex Pharmaceuticals' new $200,000-a-year cystic fibrosis drug could help 90% of patients breathe. It's an amazing--and amazingly profitable--innovation. But will that windfall spur the 28-year-old ...

Mid-stage results bring new high for Vertex

So far 2017 has been something of a golden year for US biotech firm Vertex Pharmaceuticals, but it got…

FDA and EMA accept Vertex applications for cystic fibrosis combo drug

US biotech firm Vertex Pharmaceuticals saw its shares rise 1.85% to $156.08 after the company updated…

Vertex's cystic fibrosis drug gets expanded indication

Vertex Pharmaceuticals' Kalydeco, or ivacaftor, has been approved by the FDA to cover 23 new disease-causing mutations in pat -More- 

Abstufung für Vertex Pharmaceuticals-Aktie! - Aktienanalyse

Zürich - Vertex Pharmaceuticals-Aktienanalyse von Analyst Carter Gould von der UBS: Carter Gould, Aktienanalyst der UBS, vertritt laut einer Aktienanalyse nur noch eine neutrale Haltung hinsichtlic.....

Vertex Pharmaceuticals-Aktie: Chancen sind erstklassig! - Aktienanalyse

New York - Vertex Pharmaceuticals-Aktienanalyse von Analystin Robyn Karnauskas von der Citigroup: Robyn Karnauskas, Aktienanalystin bei der Citigroup, empfiehlt die Aktien des US-Biotechkonzerns Ve...

Vertex Pharmaceuticals-Aktie: Preiserhöhung gibt Vertrauen! - Aktienanalyse

New York - Vertex Pharmaceuticals-Aktienanalyse von Analyst Philip Nadeau von Cowen and Company: Phil Nadeau, Aktienanalyst von Cowen and Company, rechnet laut einer aktuellen Aktienanalyse bei den...

Vertex to leverage X-Chem's drug discovery platform in pre-clinical research

Privately-held American biotech X-Chem is to begin collaborating with Boston-based Vertex Pharmaceuticals…

Drugs and Medications [295 Associated Drugs and Medications listed on BioPortfolio]

Minoxidil [Hi-Tech Pharmacal Co., Inc.]

Drug Facts

Hair regrowth treatment [Safeway]

Safeway Inc. Hair Regrowth Treatment for Men Drug Facts

Hair regrowth [CVS Pharmacy]

CVS Pharmacy, Inc. Hair Regrowth Treatment for Men Drug Facts

Equaline hair regrowth treatment [Supervalu Inc]

SuperValu Hair Regrowth Treatment for Men Drug Facts

Hair regrowth treatment [Meijer Distribution Inc]

Meijer Hair Regrowth Treatment for Men Drug Facts

PubMed Articles [260 Associated PubMed Articles listed on BioPortfolio]

Packing Vertex Data into Hardware-Decompressible Textures.

Most graphics hardware features memory to store textures and vertex data for rendering. However, because of the irreversible trend of increasing complexity of scenes, rendering a scene can easily reac...

GW vertex corrected calculations for molecular systems.

Hedin's scheme is solved with the inclusion of the vertex function (GWΓ) for a set of small molecules. The computational scheme allows for the consistent inclusion of the vertex both at the polarizab...

Announcing the 2017 Pharmaceuticals Travel Award for Young Post-Doctoral Researchers.

Last year, for the first time in its history, our Journal was able to offer a travel grant of 800 CHF to a young researcher in the field of medicinal chemistry.

Suspended solids moderate the degradation and sorption of waste water-derived pharmaceuticals in estuarine waters.

This study focuses on the fate of pharmaceuticals discharged into an estuarine environment, particularly into the Turbidity Maximum Zone (TMZ). Batch experiments were set up to investigate the factors...

Hybrid cell-centred/vertex model for multicellular systems with equilibrium-preserving remodelling.

We present a hybrid vertex/cell-centred model for mechanically simulating planar cellular monolayers undergoing cell reorganisation. Cell centres are represented by a triangular nodal network, while t...

Clinical Trials [204 Associated Clinical Trials listed on BioPortfolio]

Early Versus Delayed Pushing in the Second Stage of Labor

Nulliparous women in spontaneous or induced labour with term singleton pregnancy are randomized into two groups first group (early pushing) in this group patients were allowed to push with...

Study Comparing Citalopram Hydrobromide Tablets 40 mg (Torrent Pharmaceuticals Ltd) and RLD Tablets 40 mg (Manufactured By Forest Pharmaceuticals Inc, Missouri) in 24+2 Normal Healthy Male Subjects in Fed Condition

- Objective: - The objective of this study is to compare the rate and extent of absorption of the Test Product, Citalopram Hydrobromide 40 mg (Torrent Pharmaceutical Li...

Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Rosuvastatin Calcium Tablets Under Fed Conditions

Subjects to compare the single dose bioavailability of Torrent's Rosuvastatin Calcium Tablets 40 mg and Crestor® 40 mg Tablets of AstraZeneca Pharmaceuticals LP, USA. Dosing periods of st...

Cilostazol 50 mg Tablets Under Fasting Conditions

This study will compare the relative bioavailability (rate and extent of absorption) of 50 mg Cilostazol Tablets manufactured by TEVA Pharmaceuticals Industries Ltd. and distributed by TEV...

Study Comparing Citalopram Hydrobromide Tablets 40 mg (Torrent Pharmaceuticals Ltd) and RLD Tablets 40 mg (Manufactured By Forest Pharmaceuticals Inc, Missouri) in 24+2 Normal Healthy Male Subjects Under Fasting Condition

- Objective: - To compare the rate and extent of absorption of Citalopram Hydrobromide Tablets 40 mg: Test Product: Citalopram Hydrobromide Tablets 40 mg manufactured b...

Companies [1280 Associated Companies listed on BioPortfolio]

Vertex Pharmaceuticals Inc.

Vertex is a global biotechnology company that aims to discover, develop and commercialize innovative new medicines so people with serious diseases can lead better lives. Founded in 1989, Vertex toda...

Vertex Pharmaceuticals Incorporated

Second Quarter and Six Month Results

LaVoie Group

LaVoie Group provides senior-level strategic counsel and tactical implementation of strategic communications programs designed to properly position, create visibility and drive value for each client. ...

BioAxone BioSciences, Inc.

BioAxone BioSciences is a clinical-stage biotechnology company developing innovative drugs to restore neurological function for patients with Spinal Cord Injuries (SCI) and other ...

Maelor Pharmaceuticals Ltd.

Maelor is a publicly listed (AIM:MLR) specialist critical care pharmaceuticals and devices company. The Company has developed an expertise in bringing both pharmaceuticals and devices to the market as...

More Information about "Vertex Pharmaceuticals Inc." on BioPortfolio

We have published hundreds of Vertex Pharmaceuticals Inc. news stories on BioPortfolio along with dozens of Vertex Pharmaceuticals Inc. Clinical Trials and PubMed Articles about Vertex Pharmaceuticals Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Vertex Pharmaceuticals Inc. Companies in our database. You can also find out about relevant Vertex Pharmaceuticals Inc. Drugs and Medications on this site too.

Quick Search

Relevant Topics

Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

Astroesophageal Reflux Disease (GERD) Barrett's Esophagus Celiac Disease Cholesterol Crohn's Disease Gastroenterology Hepatitis Hepatology Irritable Bowel Syndrome (IBS) Pancreatitis Peptic Ulcer Disease...

Corporate Database Quicklinks

Searches Linking to this Company Record